Rhenovia Pharma

Provider of biosimulation technology for CNS drug discovery and development

placeMulhouse, Grand Est, France calendar_todayFounded 2007 language rhenovia.com

Innovation

3 patent families (1 granted) — focus: Human necessities; filing pace dormant. Cited 41 times.

YearFilings
20132
20143

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon